UBS Group »

Editas Medicine shares owned by UBS Group

Quarter-by-quarter ownership of Editas Medicine (EDIT) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Editas Medicine

Tip: Access up to 7 years of quarterly data

All positions including Editas Medicine held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Editas Medicine by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.5M 144k 10.13
2023-09-30 $849k 109k 7.80
2023-06-30 $1.5M 186k 8.23
2023-03-31 $3.6M 498k 7.25
2022-12-31 $3.6M 407k 8.87
2022-09-30 $1.1M 89k 12.24
2022-06-30 $3.3M 281k 11.83
2022-03-31 $4.6M 242k 19.02
2021-12-31 $3.8M 141k 26.55
2021-09-30 $3.9M 96k 41.07
2021-06-30 $5.7M 100k 56.64
2021-03-31 $2.4M 57k 42.00
2020-12-31 $6.2M 88k 70.26
2020-09-30 $1.7M 62k 28.07
2020-06-30 $2.0M 69k 29.58
2020-03-31 $1.1M 57k 19.83
2019-12-31 $2.9M 97k 29.55
2019-09-30 $5.4M 238k 22.74
2019-06-30 $2.9M 118k 24.74
2019-03-31 $3.1M 128k 24.45
2018-12-31 $2.3M 100k 22.74
2018-09-30 $4.1M 130k 31.84
2018-06-30 $3.5M 94k 36.81
2018-03-31 $7.1M 214k 33.15
2017-12-31 $3.4M 111k 30.74
2017-09-30 $3.7M 154k 24.01
2017-06-30 $1.5M 92k 16.78
2017-03-31 $1.7M 78k 22.32
2016-12-31 $150k 9.2k 16.23
2016-09-30 $411k 31k 13.49
2016-06-30 $429k 17k 24.79
2016-03-31 $452k 13k 34.50